A Malignant Flu

A Malignant Flu May Soon Evolve to Infect and Kill Humans, Report Says
© Getty Images

Vaccines for Your Children By Age | CDC
I get it when I was a kid I had Measels, Mumps and chicken pox on my list, but I lived through them. But today those childhood disease rarely happens because of vaccines. However. the mandatory vaccine requirements can make a kid feel like a pin cushion
and be a bit overwhelming.

A mink farm in Spain is the site of research regarding the spread of avian influenza.
Researchers believe the bird flu was transmitted across minks in the farm—a troubling mammal-to-mammal spread. The outbreak at mink farms opens a new worry for health researchers. Scientists fear that that mammal-to-mammal transmission could lead to global catastrophe.

RELATED VIDEO: How to deal with the Influenza virus
which is spreading across states (India Today) – Bing video

Last fall, on a mink farm in Spain, H5N1 (avian influenza) spread across the animals.
The outbreak also resulted in the death or culling of the entire group of 50,000 minks.
Why should you care? Because it may have marked the first known case of mammal-to-mammal transmission of the deadly virus known as the bird flu, according to a new study. And that doesn’t portend anything good for humans.
The bird flu has proven scary enough with its occasional spread from birds to mammals of all sorts, but the study published in Eurosurveillance calls the latest devastation of mink illnesses and deaths especially concerning. “Our findings also indicate that an onward transmission of the virus to other minks may have taken place in the affected farm,”
the study authors write.

That raises the alarm that humans could be next.
“This signals the very real potential for the emergence of mammal-to-mammal transmission,” Michelle Wille, a University of Sydney researcher, tells CBC News.
“It could have deadly consequences,” Isaac Bogoch, an infectious disease specialist, tells CBC News. “This is an infection that has epidemic and pandemic potential.
I don’t know if people recognize how big a deal this is.” Well, that’s comforting.

Well, that’s comforting.
The H5N1 avian influenza is notorious for a near 100-percent mortality rate in birds. While mammals aren’t catching the virus at the same rate as birds, they aren’t immune
to the effects: bird flu has a global WHO mortality rate of greater than 50 percent for humans.
So far, the human infections link to contact with an infected bird, which is why the mammal-to-mammal possibility becomes the troubling part of this entire scenario.
If a mammal, such as a mink, can become an intermediary host, the virus can then
mutate to pose an even greater risk to other mammals, including humans.

“And so what’s concerning about this.”
Louise Moncla, a University of Pennsylvania school of veterinary medicine assistant professor, tells CBC News, “is that this is exactly the kind of scenario you would expect
to see that could lead to this type of adaptation, that could allow these viruses to replicate better in other mammals—like us.”After weeks of suffering from fatigue and shortness of breath in the fall of 2016, Hunter Brady went to the doctor, who diagnosed him with the flu. But when the 16-year-old’s prescribed treatment didn’t relieve his symptoms, a second opinion revealed the Florida boy had stage 4 Hodgkin lymphoma. Fatigue, chills, fever, weight loss, swollen lymph nodes and persistent cough are common symptoms of the flu. But they also are common symptoms of some cancers, especially hematologic malignancies, such as lymphoma and leukemia.

As flu season approaches, there may be rare cases when patients who think they have
the flu are later diagnosed with cancer, says Mashiul Chowdhury, MD, Chief of Infectious Diseases at Cancer Treatment Centers of America® (CTCA), though he says there is no need for anyone to be alarmed, stressing that the occurrences are rare.
“The symptoms of the flu or an infection often are similar to symptoms of cancer because some of the mechanisms are quite similar,” Dr. Chowdhury says. “Your immune system is down. So, you feel a malaise, you have a fever. Then you go to get a chest X-ray and you get a bad surprise—cancer.”

Cases of common symptoms.
While it is rare for cancer to be inaccurately diagnosed as the flu, several cases have made headlines. For instance: In 2012, a woman who fought through weeks of flu symptoms was later treated at the Mayo Clinic in Jacksonville, Florida, for thyroid cancer.
In 2016, Jaime Luis Gomez, known as rapper Taboo and a former member of pop group The Black Eyed Peas, said in an interview that he thought his pain, headaches and shortness of breath were brought on by the flu. He was later diagnosed with stage 2 testicular cancer.
The inaccurate diagnoses should not cause panic. Dr. Chowdhury says patients who
have been diagnosed with the flu or have flu-like symptoms should not be alarmed or immediately think they have something other than the flu. But if symptoms worsen or do not get better after two weeks, they should see a doctor. “If you have an infection, and this is especially important for older people, and it lasts longer than the average period, then there should be concern,” Dr. Chowdhury says. “Then you need to go tell your doctor this is not going away.”

Cancer may increase flu risk.
It’s also important to know that patients who are undergoing cancer treatment may
be at a higher risk for catching the flu, because their immune system may be weak.
As flu season approaches, here are some tips for cancer patients and their caregivers
that may help reduce the risk of getting sick: Get the flu vaccine.

The American Cancer Society says flu vaccines are safe for cancer patients.
But check with your doctor first. Make sure your family members and caregivers
also are vaccinated. Avoid crowds or wear a mask if you must be in a large group.

Wash hands frequently.
If you think you may have been exposed to the flu, talk to your doctor as soon as possible. A doctor may choose to prescribe prophylactic antibiotics that may ease symptoms or prevent the flu from developing. Learn more about the flu-like symptoms associated with leukemiaHodgkin lymphoma and non-Hodgkin lymphoma.

Cancer patients and the COVID-19 vaccines
Dr. Steven Pergam of the Fred Hutchinson Cancer Research Center receiving his first dose of a COVID-19 vaccine on December 29, 2020. Image: courtesy of Dr. Steven Pergam.

COVID-19 Vaccines and People with Cancer.
Many people being treated for cancer have questions about COVID-19 vaccines and
how COVID may affect their cancer treatment. This Q&A was developed in consultation
with Steven Pergam, M.D., of the Fred Hutchinson Cancer Research Center in Seattle, to answer some of those questions. Dr. Pergam was a co-leader of a committee formed by the National Comprehensive Cancer Network (NCCN) that developed recommendations on COVID-19 vaccination in cancer patients
If you have a question that isn’t answered here, click the “Chat Now” button in the box below to connect with an NCI information specialist. CDC, NCCN, and other cancer-related organizations urge cancer patients to get COVID-19 vaccinations and booster shots. Why?
Data show that people with cancer and others with weakened immune systems are at
high risk for severe complications from COVID-19. Vaccines have been shown to decrease the risk of hospitalization and death from COVID-19, even among people with cancer.
Plus, we now have evidence that the virus can persist in immunocompromised people, which may lead to the rise of new variants. Therefore, vaccinating these individuals—
and the population as a whole—continues to be important to slow the spread of the
virus and save lives.

COVID-19 Vaccine Recommendations.
The Centers for Disease Control (CDC) and Prevention recommends that everyone aged
6 months and older stay up to date with COVID-19 vaccination. That includes most people with underlying medical conditions, including cancer.
Are there any patients undergoing active cancer treatment who should not get vaccinated?
For patients who have just had a stem cell transplant or received CAR T-cell therapy, who are typically receiving immunosuppressive therapy, we continue to recommend that they delay COVID-19 vaccination (or revaccination as is recommended for patients undergoing these therapies) until at least 3 months after they’ve completed treatment. That’s based on data that [other] vaccines have had limited efficacy during periods when these patients are their most immunosuppressed.

All other patients who are being treated for cancer, including those getting aggressive chemotherapy, should get vaccinated and boosted without delay. Will receiving the vaccine during cancer treatment make the cancer treatment less effective?
No. There is no evidence that any vaccines, including COVID-19 vaccines, make cancer therapy less effective. And survivors, those not undergoing active cancer treatment.
Are there any reasons they shouldn’t get vaccinated?
Many cancer survivors have weakened immune systems, so they may be at high risk of severe and/or persistent COVID-19. Cancer survivors also tend to be older and have other comorbidities—heart disease, kidney or lung dysfunction—so they’re going to have other reasons that will put them at risk for developing severe COVID-19.
These are all reasons for them to get vaccinated.


COVID-19: What People with Cancer Should Know

Learn how to protect yourself from COVID-19 and find the latest guidance
on vaccines and boosters. And what about those who may be undergoing treatment soon, such as somebody just diagnosed with cancer or whose treatment has been delayed by the pandemic?
The best approach is to get the vaccine as soon as you can. However, we do recommend delays for patients undergoing stem cell transplant and those getting CAR T-cell therapy. In addition, cancer patients who are about to undergo surgery should wait a few days to up to 2 weeks after surgery to get vaccinated. This helps doctors know whether any symptoms—for example, a fever—are due to the surgery or the vaccine.

Can COVID-19 vaccines cause cancer?
Can the vaccines cause cancer to recur or make it more aggressive?
There is no evidence that COVID-19 vaccines cause cancer, lead to recurrence, or
lead to disease progression. Furthermore, COVID-19 vaccines do not change your DNA (i.e., your genetic code). Can getting vaccinated cause a rise in tumor markers or signs of cancer recurrence just after a vaccination?
We are not aware of any evidence that suggests vaccines can affect cancer biomarkers in this way. However, we do know that the Pfizer and Moderna vaccines can lead to enlarged lymph nodes, particularly those in your armpit, called axillary lymph nodes. Developing new swelling in the armpit of your vaccinated arm a few days after getting your shot likely means the vaccine is producing a good immune response.

Some recently vaccinated people who have had imaging scans have had these lymph
nodes “light up,” so our committee recommends talking to your cancer care team about any upcoming scans to make sure that they are aware of your recent vaccine.

They may want to delay your scan unless it is urgent.
If you do get swelling after being vaccinated, and it doesn’t go away after about a week, make sure to tell your doctor.I have lymphedema from lymph node surgery in one of my arms.

Can I still get the shot in that arm?
Patients with lymphedema or those who have had a lymph node dissection in one arm,
say for treatment of breast cancer, should get vaccinated in the other arm. Patients with lymphedema are at increased risk of infection and should avoid vaccinations in the affected arm.

If you have lymphedema in both arms, then the thigh can also be used as an alternate
site for vaccine injection. In either case, if you have any lymphedema or have had a lymph node dissection, make sure you tell the personnel working at the vaccination site and they can vaccinate you in your other arm.
Is one COVID-19 vaccine better than another for people with cancer or cancer survivors?
In most situations, the bivalent Pfizer-BioNTech or Moderna COVID-19 mRNA vaccines are preferred over the protein subunit Novavax vaccine or the adenovirus-vector Johnson & Johnson/Janssen vaccine. However, the Novavax or Johnson & Johnson/Janssen vaccine can be used in people who cannot or will not receive an mRNA vaccine. 
Are researchers collecting data on how effective the vaccines are in people with cancer?

A number of research groups are studying COVID-19 vaccine efficacy in people with cancer, from those with solid tumors to those receiving bone marrow transplants.
For example, there are researchers looking at people who have blood cancers, like CLL or CML, because they are more likely to have immunodeficiency over a long period of time. Data from immunosuppressed patient populations have indicated that additional COVID-19 vaccine doses in the primary series and boosters can help improve immune responses in some people with cancer.

How do my patients respond to these vaccines?
Every cancer doctor wants to know the answer to the question:
There are lots of analyses that still need to be done—and so many subgroups of cancer patients and cancer treatments that require additional study. The more data we have that characterize vaccine responses in individual cancer populations, the better we can advise patients. Do COVID-19 vaccines provide less protection to cancer patients or survivors?

A nurse administering a vaccine to an older Black woman.
COVID-19 Vaccine Protection Limited in Some People with Cancer


Vaccines appear to be least effective in people with blood cancers, studies find.


Studies show that, compared with people who have never had cancer, COVID vaccines may be less effective in some people with cancer—in particular, patients with blood cancers (such as leukemia and lymphoma) or those receiving aggressive chemotherapy that weakens their immune systems.
The expectation is that most patients will respond to the vaccine.
Patients with cancer may not see the 90% protection from hospitalization
[from the Pfizer and Moderna vaccines] seen in the general public.
But any amount of protection is still a major benefit—particularly since these vaccines are best at preventing major complications from COVID-19. Guidelines for the general public change based on community risk, novel variants & vaccine levels throughout the country.

However, layers of prevention remain important for people with cancer, even if they
are vaccinated, particularly those with hematologic malignancies, those who are getting chemotherapy or radiation, and those with other health conditions known to increase risk for COVID-19. We continue to recommend that these patients wear masks when in public places and avoid large get-togethers and crowds. These efforts are important because if you get COVID-19 it may lead to delays in your cancer treatment.
Existing COVID-19 vaccines do not prevent COVID-19 in all of those who get vaccinated, but they can prevent cancer patients from developing severe COVID-19 disease or hospitalization. What about family members and caregivers of those with cancer?

Is it important that they get vaccinated?
This is an underappreciated question. If you think about a vaccine strategy, if some
people with cancer aren’t going to be fully protected by the COVID-19 vaccine, one of the best ways to protect them is to give the vaccine to people who will respond well. And that means anybody who they spend time with. So, anybody who is a caregiver, a loved one, or is in close contact with somebody with cancer, it’s important for them to get vaccinated and boosted, wear masks when out and about, avoid crowds, and take any other preventive measures.

These steps can help decrease a caregiver’s risk of developing symptomatic infections
and symptomatic people are more likely to transmit the virus to people around them.
Vaccines and other precautions are also thought to help prevent transmission.
So, when caregivers and loved ones take precautions, they may be less likely to get the virus and bring it home. How do you see the approach to vaccination and booster shots changing over the coming months and years?
We know that immunity to coronaviruses, including SARS-CoV-2, wanes over time. Additionally, viral variants like Omicron can emerge that are better able to escape our immune responses. For these reasons, yearly boosters may be needed. Further research into the frequency and timing of additional boosters is ongoing, as are studies looking at more “variant-specific” boosters. 
 
BONUS: Are vaccines Safe for Cancer Patients – Bing video
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

Time limit is exhausted. Please reload the CAPTCHA.